Article
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
The Journal of Rheumatology
(2018)
Disciplines
Publication Date
December 15, 2018
DOI
10.3899/jrheum.181077
Citation Information
Ana-Maria Orbai, Richard Holland, Ying Ying Leung, William Tillett, et al.. "PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials" The Journal of Rheumatology (2018) Available at: http://works.bepress.com/philip-mease/320/